{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:15:10Z","timestamp":1761920110970},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T00:00:00Z","timestamp":1476230400000},"content-version":"vor","delay-in-days":276,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Motivation: Novel approaches are needed for discovery of targeted therapies for non-small-cell lung cancer (NSCLC) that are specific to certain patients. Whole genome RNAi screening of lung cancer cell lines provides an ideal source for determining candidate drug targets.<\/jats:p><jats:p>Results: Unsupervised learning algorithms uncovered patterns of differential vulnerability across lung cancer cell lines to loss of functionally related genes. Such genetic vulnerabilities represent candidate targets for therapy and are found to be involved in splicing, translation and protein folding. In particular, many NSCLC cell lines were especially sensitive to the loss of components of the LSm2-8 protein complex or the CCT\/TRiC chaperonin. Different vulnerabilities were also found for different cell line subgroups. Furthermore, the predicted vulnerability of a single adenocarcinoma cell line to loss of the Wnt pathway was experimentally validated with screening of small-molecule Wnt inhibitors against an extensive cell line panel.<\/jats:p><jats:p>Availability and implementation: The clustering algorithm is implemented in Python and is freely available at https:\/\/bitbucket.org\/youngjh\/nsclc_paper.<\/jats:p><jats:p>Contact: \u00a0marcotte@icmb.utexas.edu or jon.young@utexas.edu<\/jats:p><jats:p>Supplementary information: \u00a0Supplementary data are available at Bioinformatics online.<\/jats:p>","DOI":"10.1093\/bioinformatics\/btw010","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T01:09:07Z","timestamp":1455498547000},"page":"1373-1379","source":"Crossref","is-referenced-by-count":10,"title":["Computational discovery of pathway-level genetic vulnerabilities in non-small-cell lung cancer"],"prefix":"10.1093","volume":"32","author":[{"given":"Jonathan H.","family":"Young","sequence":"first","affiliation":[{"name":"1 Institute for Computational Engineering and Sciences, University of Texas at Austin, Austin, TX, USA,"},{"name":"2 Center for Systems and Synthetic Biology and Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Peyton","sequence":"additional","affiliation":[{"name":"3 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun","family":"Seok Kim","sequence":"additional","affiliation":[{"name":"4 Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"McMillan","sequence":"additional","affiliation":[{"name":"5 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Minna","sequence":"additional","affiliation":[{"name":"3 Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"White","sequence":"additional","affiliation":[{"name":"5 Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Marcotte","sequence":"additional","affiliation":[{"name":"1 Institute for Computational Engineering and Sciences, University of Texas at Austin, Austin, TX, USA,"},{"name":"2 Center for Systems and Synthetic Biology and Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,1,10]]},"reference":[{"key":"2023020112220520400_btw010-B1","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1158\/1535-7163.MCT-09-0051","article-title":"Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells","volume":"8","author":"Albert","year":"2009","journal-title":"Mol. Cancer Ther"},{"key":"2023020112220520400_btw010-B2","first-page":"1027","article-title":"k-means\u2009++: the advantages of careful seeding","author":"Arthur","year":"2007","journal-title":"Proc. Eighteenth Annual ACM-SIAM Symposium on Discrete Algorithms"},{"key":"2023020112220520400_btw010-B3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. B"},{"key":"2023020112220520400_btw010-B4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2011.09.006","article-title":"Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer","volume":"76","author":"Besse","year":"2012","journal-title":"Lung Cancer"},{"key":"2023020112220520400_btw010-B5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrd3823","article-title":"The spliceosome as a target of novel antitumour drugs","volume":"11","author":"Bonnal","year":"2012","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023020112220520400_btw010-B6","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/0008-5472.CAN-11-2848","article-title":"Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition","volume":"72","author":"Cas\u00e1s-Selves","year":"2012","journal-title":"Cancer Res"},{"key":"2023020112220520400_btw010-B7","doi-asserted-by":"crossref","first-page":"12372","DOI":"10.1073\/pnas.1109363108","article-title":"Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies ovarian cancer","volume":"108","author":"Cheung","year":"2011","journal-title":"Proc. Natl Acad. Sci. U.S.A"},{"key":"2023020112220520400_btw010-B8","doi-asserted-by":"crossref","first-page":"140035","DOI":"10.1038\/sdata.2014.35","article-title":"Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies","volume":"1","author":"Cowley","year":"2014","journal-title":"Sci. Data"},{"key":"2023020112220520400_btw010-B9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nrd4389","article-title":"Drugging the undruggable Ras: mission possible?","volume":"13","author":"Cox","year":"2014","journal-title":"Nat. Rev. Drug Discov"},{"key":"2023020112220520400_btw010-B10","doi-asserted-by":"crossref","first-page":"e73710","DOI":"10.1371\/journal.pone.0073710","article-title":"Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer","volume":"8","author":"Cron","year":"2013","journal-title":"PLoS One"},{"key":"2023020112220520400_btw010-B11","doi-asserted-by":"crossref","first-page":"4647s","DOI":"10.1158\/1078-0432.CCR-07-0334","article-title":"Incorporating bortezomib into the treatment of lung cancer","volume":"13","author":"Davies","year":"2007","journal-title":"Clin. Cancer Res"},{"key":"2023020112220520400_btw010-B12","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/embor.2008.189","article-title":"The emerging role of splicing factors in cancer","volume":"9","author":"Grosso","year":"2008","journal-title":"EMBO Rep"},{"key":"2023020112220520400_btw010-B13","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1158\/0008-5472.CAN-12-0026","article-title":"Translation regulation as a therapeutic target in cancer","volume":"72","author":"Grzmil","year":"2012","journal-title":"Cancer Res"},{"key":"2023020112220520400_btw010-B14","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cell.2012.08.011","article-title":"A census of human soluble protein complexes","volume":"150","author":"Havugimana","year":"2012","journal-title":"Cell"},{"key":"2023020112220520400_btw010-B15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc"},{"key":"2023020112220520400_btw010-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"2023020112220520400_btw010-B17","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1073\/pnas.1404639111","article-title":"In situ selectivity profiling and crystal structure of SML-8-73-1, an active site inhibitor of oncogenic K-Ras G12C","volume":"111","author":"Hunter","year":"2014","journal-title":"Proc. Natl Acad. Sci. U.S.A"},{"key":"2023020112220520400_btw010-B18","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/JTO.0b013e318267928d","article-title":"Phase I trial of induction histone deacetylase and proteasome inhibition followed by surgery in non-small-cell lung cancer","volume":"7","author":"Jones","year":"2012","journal-title":"J. Thorac. Oncol"},{"key":"2023020112220520400_btw010-B19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.cell.2013.09.041","article-title":"Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer","volume":"155","author":"Kim","year":"2013","journal-title":"Cell"},{"key":"2023020112220520400_btw010-B20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.chembiol.2012.01.003","article-title":"Proteasome inhibitors: an expanding army attacking a unique target","volume":"19","author":"Kisselev","year":"2012","journal-title":"Chem. Biol"},{"key":"2023020112220520400_btw010-B21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.2012.43.4522","article-title":"Role of epidermal growth factor receptor inhibitors in epidermal growth factor receptor wild-type non-small-cell lung cancer","volume":"31","author":"Laurie","year":"2013","journal-title":"J. Clin. Oncol"},{"key":"2023020112220520400_btw010-B22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1756-9966-28-110","article-title":"Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction","volume":"28","author":"Li","year":"2009","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"2023020112220520400_btw010-B23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cell.2012.07.023","article-title":"Cancer vulnerabilities unveiled by genomic loss","volume":"150","author":"Nijhawan","year":"2012","journal-title":"Cell"},{"key":"2023020112220520400_btw010-B24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1534\/genetics.110.117655","article-title":"Trivalent arsenic inhibits the functions of chaperonin complex","volume":"186","author":"Pan","year":"2010","journal-title":"Genetics"},{"key":"2023020112220520400_btw010-B25","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1007\/s11033-011-1218-z","article-title":"Arsenic trioxide induces human pulmonary fibroblast cell death via the regulation of Bcl-2 family and caspase-8","volume":"39","author":"Park","year":"2012","journal-title":"Mol. Biol. Rep"},{"key":"2023020112220520400_btw010-B26","first-page":"2825","article-title":"Scikit-learn: machine learning in python","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res"},{"key":"2023020112220520400_btw010-B27","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1054\/bjoc.2001.1828","article-title":"Identification of a 170-kDa protein over-expressed in lung cancers","volume":"84","author":"Pincheira","year":"2001","journal-title":"Br. J. Cancer"},{"key":"2023020112220520400_btw010-B28","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/JTO.0b013e31824de2fa","article-title":"Phase-I\/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer","volume":"7","author":"Piperdi","year":"2012","journal-title":"J. Thorac. Oncol"},{"key":"2023020112220520400_btw010-B29","doi-asserted-by":"crossref","first-page":"D497","DOI":"10.1093\/nar\/gkp914","article-title":"CORUM: the comprehensive resource of mammalian protein complexes-2009","volume":"38(Suppl. 1)","author":"Ruepp","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2023020112220520400_btw010-B30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/gbe\/evt074","article-title":"All or nothing: protein complexes flip essentiality between distantly related eukaryotes","volume":"5","author":"Ryan","year":"2013","journal-title":"Genome Biol. Evol"},{"key":"2023020112220520400_btw010-B31","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1214\/09-AOAS239","article-title":"Finding large average submatrices in high dimensional data","volume":"3","author":"Shabalin","year":"2009","journal-title":"Ann. Appl. Stat"},{"key":"2023020112220520400_btw010-B32","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1200\/JCO.2012.44.5353","article-title":"ALK in lung cancer: past, present, and future","volume":"31","author":"Shaw","year":"2013","journal-title":"J. Clin. Oncol"},{"key":"2023020112220520400_btw010-B33","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood.V89.9.3354","article-title":"Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients","volume":"89","author":"Shen","year":"1997","journal-title":"Blood"},{"key":"2023020112220520400_btw010-B34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5808\/GI.2013.11.1.55","article-title":"siMacro: a fast and easy data processing tool for cell-based genomewide siRNA screens","volume":"11","author":"Singh","year":"2013","journal-title":"Genomics Inf"},{"key":"2023020112220520400_btw010-B35","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJM199811053391901","article-title":"Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide","volume":"339","author":"Soignet","year":"1998","journal-title":"N. Engl. J. Med"},{"key":"2023020112220520400_btw010-B36","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2001.19.18.3852","article-title":"United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia","volume":"19","author":"Soignet","year":"2001","journal-title":"J. Clin. Oncol"},{"key":"2023020112220520400_btw010-B37","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/1467-9868.00346","article-title":"A direct approach to false discovery rates","volume":"64","author":"Storey","year":"2002","journal-title":"J. R. Stat. Soc. Ser. B. Stat. Methodol"},{"key":"2023020112220520400_btw010-B38","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/sj.bjc.6604801","article-title":"The spliceosome as target for anticancer treatment","volume":"100","author":"van Alphen","year":"2009","journal-title":"Br. J. Cancer"},{"key":"2023020112220520400_btw010-B39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.32614\/RJ-2011-015","article-title":"Ckmeans.1d.dp: Optimal k-means clustering in one dimension by dynamic programming","volume":"3","author":"Wang","year":"2011","journal-title":"R Journal"},{"key":"2023020112220520400_btw010-B40","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1074\/jbc.M606284200","article-title":"Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells","volume":"282","author":"Zhang","year":"2007","journal-title":"J. Biol. Chem"}],"container-title":["Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/32\/9\/1373\/49019189\/bioinformatics_32_9_1373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article-pdf\/32\/9\/1373\/49019189\/bioinformatics_32_9_1373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:40:29Z","timestamp":1718361629000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bioinformatics\/article\/32\/9\/1373\/1744487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,10]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bioinformatics\/btw010","relation":{},"ISSN":["1367-4811","1367-4803"],"issn-type":[{"value":"1367-4811","type":"electronic"},{"value":"1367-4803","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,5,1]]},"published":{"date-parts":[[2016,1,10]]}}}